IP Library Granted Patent US 9,880,172
Granted Patent B2
US 9,880,172 · App. 14/859,742 · Granted Jan 30, 2018

Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability

Inventor: Joshua S. Salafsky (San Francisco, CA)
Assignee: Biodesy, Inc.
G01N33/582G01N21/6428G01N33/54373G01N33/6803G01N21/6445G01N2021/6441G01N2500/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,880,172
App. No.
14/859,742
Granted
Jan 30, 2018
Kind
B2
Abstract

A system for making molecules, and proteins in particular, suitable for detection by a surface-selective nonlinear optical technique. A first use of the invention is for determining a protein's structure in real space and real time. A second use of the invention is to detect a protein or its activity (conformational change). A third use of the invention is for drug screening. A further aspect of the present invention is measuring probe tilt angle orientation in an oriented protein.

Claims (24)

1. A method comprising:

(a) preparing one or more mutants of a protein by incorporating one or more unnatural amino acid(s) that are second harmonic (SH)-active or sum frequency (SF)-active into the protein;

(b) immobilizing the protein mutants on a surface so as to produce a net orientation of the one or more unnatural amino acid(s) relative to the surface;

(c) measuring a tilt angle of the one or more of the unnatural amino acid(s) relative to the surface in the one or more protein mutants;

(d) determining a structure of the protein using the tilt angle measured in (c).

2. The method of claim 1 , further comprising exposing the one or more mutants of the protein to a second molecule.

3. The method of claim 2 wherein the second molecule is a ligand, a compound, a small molecule, a drug, a peptide, an inhibitor, or a protein.

4. The method of claim 1 wherein the one or more mutant proteins are arrayed on a surface.

5. The method of claim 1 wherein the structure is comprised of real space coordinates of the protein.

6. The method of claim 5 wherein the coordinates are of a particular atom, molecule, group of atoms, or group of protein molecules.

7. The method of claim 1 , wherein the tilt angle is measured in real time.

8. The method of claim 1 , wherein determining the structure of the protein comprises determining a conformational change of the protein.

9. The method of claim 8 , wherein the conformational change is determined in real time and space.

10. The method of claim 9 , wherein the conformational change is determined in real time and space simultaneously.

11. The method of claim 1 , wherein determining the structure of the protein comprises determining structural changes for both buried and surface sites.

12. The method of claim 1 , wherein the tilt angle is an absolute tilt angle relative to the surface.

13. The method of claim 1 , wherein preparing one or more mutants of a protein comprise genetically incorporating a series of unnatural amino acids into different mutants of the protein.

14. The method of claim 1 , further comprising determining a three-dimensional structure of the protein.

15. The method of claim 1 , further comprising comparing the determined structure with a X-ray crystal structure of the protein.

16. The method of claim 1 , wherein the unnatural amino acid is Aladan.

17. The method of claim 1 , wherein the at least one of the one or more unnatural amino acid(s) are incorporated into a buried residue of the protein.

18. The method of claim 1 , wherein the one or more unnatural amino acid(s) are incorporated into the protein site-specifically.

19. The method of claim 1 , further comprising incorporation of a different unnatural amino acid into the protein.

20. The method of claim 19 , wherein the different unnatural amino acid is not second-harmonic active.

Assignments (3)
CHANGE OF NAME Recorded Jun 24, 2020
From: BIODESY, INC.
To: BLUELIGHT THERAPEUTICS, INC.
Reel/Frame 053834/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2015
From: SALAFSKY, JOSHUA S.
To: BIODESY, LLC
Reel/Frame 036646/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2015
From: BIODESY, LLC
To: BIODESY, INC.
Reel/Frame 036675/0783 →
Continuity (3)
Division 12535631 · Aug 4, 2009
Provisional Application 61137773 · Aug 4, 2008
Related Publication 20160077099A1 · Mar 17, 2016